Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07247084 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)

Name: A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK) — clinical trial record (NCT07247084)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 4

SponsorEli Lilly and Company

Started2025-11-24

View on ClinicalTrials.gov ↗

The purpose of this study is to evaluate tirzepatide within a real-world setting to assess body weight loss and incidence of type 2 diabetes in adults without diabetes who have obesity and at least one weight-related comorbid condition. Participation in the study will last about 260 weeks.

Amendment history 1 change detected by DataLookout

2026-04-18

Trial sites expanded: 25 → 30 locations

Trial Details

NCT Number	NCT07247084
Lead Sponsor	Eli Lilly and Company
Conditions	Obesity
Enrollment	3,000 participants
Start Date	2025-11-24
Primary Completion	2029-07 (estimated)
Study Completion	2032-07 (estimated)
Updated on ClinicalTrials.gov	2026-07-07